Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
The European Commission signs a third contract with Pfizer and BioNTech to secure 1.8 billion doses of its vaccine. 2021-05-20
Novartis signs an agreement with Pfizer and BioNTech to help produce their vaccine. 2021-01-29
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Singapore officially begins its vaccination campaign against COVID-19, with healthcare workers being among the first to receive the Pfizer-BioNTech vaccine tozinameran. 2020-12-30
Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country. 2020-12-24
President-elect Joe Biden and incoming First Lady Dr. Jill Biden receive their first shot of the Pfizer BioNTech vaccine on live television to reassure Americans of the safety of vaccines. Meanwhile, Vice President-elect Kamala Harris and incoming Second Gentleman Doug Emhoff announce that they will receive their vaccines next week. 2020-12-21
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week. 2020-12-2
The government announces that they have signed a deal with Pfizer and BioNTech to purchase 1.5 million vaccine doses for 750,000 people in the country. 2020-10-11